Question

I am a breastfeeding mother and i want to know if it is safe to use Regional Ileitis, Crohn´s disease (maternal)? Is Regional Ileitis, Crohn´s disease (maternal) safe for nursing mother and child? Does Regional Ileitis, Crohn´s disease (maternal) extracts into breast milk? Does Regional Ileitis, Crohn´s disease (maternal) has any long term or short term side effects on infants? Can Regional Ileitis, Crohn´s disease (maternal) influence milk supply or can Regional Ileitis, Crohn´s disease (maternal) decrease milk supply in lactating mothers?

Regional Ileitis, Crohn´s disease (maternal) lactation summary

Regional Ileitis, Crohn´s disease (maternal) usage has low risk in breastfeeding
  • DrLact safety Score for Regional Ileitis, Crohn´s disease (maternal) is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of Regional Ileitis, Crohn´s disease (maternal) may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that Regional Ileitis, Crohn´s disease (maternal) may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of Regional Ileitis, Crohn´s disease (maternal) low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using Regional Ileitis, Crohn´s disease (maternal) We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About Regional Ileitis, Crohn´s disease (maternal) usage in lactation

Medication used is compatible with breastfeeding. Follow-up premature newborns for jaundice (risk of sulfasalazine to compete with bilirrubin metabolism)
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.